Selective STING stimulation in dendritic cells primes antitumor T cell responses.
Jneid B, Bochnakian A, Hoffmann C, Delisle F, Djacoto E, Sirven P, Denizeau J, Sedlik C, Gerber-Ferder Y, Fiore F, Akyol R, Brousse C, Kramer R, Walters I, Carlioz S, Salmon H, Malissen B, Dalod M, Piaggio E, Manel N.
Sci Immunol. 2023 Jan 13;8(79):eabn6612. doi: 10.1126/sciimmunol.abn6612. Epub 2023 Jan 13.
T cell depletion increases humoral response by favoring T follicular helper cells expansion.
Gassen RB, Borges TJ, Pérez-Sáez MJ, Zhang H, Al Jurdi A, Llinàs-Mallol L, Aoyama B, Lima M, Pascual J, Sage PT, Murakami N, Riella LV.
Am J Transplant. 2022 Jul;22(7):1766-1778. doi: 10.1111/ajt.17038. Epub 2022 Apr 15.
Application of blinatumomab, a bispecific anti-CD3/CD19 T-cell engager, in treating severe systemic sclerosis: A case study.
Subklewe M, Magno G, Gebhardt C, Bücklein V, Szelinski F, Arévalo HJR, Hänel G, Dörner T, Zugmaier G, von Bergwelt-Baildon M, Skapenko A, Schulze-Koops H.
Eur J Cancer. 2024 Jun;204:114071. doi: 10.1016/j.ejca.2024.114071. Epub 2024 Apr 22.
Haploidentical transplants using ex vivo T-cell depletion.
Martelli MF, Aversa F.
Semin Hematol. 2016 Oct;53(4):252-256. doi: 10.1053/j.seminhematol.2016.07.001. Epub 2016 Jul 25.
Restoration of T-cell homeostasis after T-cell depletion.
Mackall CL, Hakim FT, Gress RE.
Semin Immunol. 1997 Dec;9(6):339-46. doi: 10.1006/smim.1997.0091.
Both intratumoral regulatory T cell depletion and CTLA-4 antagonism are required for maximum efficacy of anti-CTLA-4 antibodies.
Lax BM, Palmeri JR, Lutz EA, Sheen A, Stinson JA, Duhamel L, Santollani L, Kennedy A, Rothschilds AM, Spranger S, Sansom DM, Wittrup KD.
Proc Natl Acad Sci U S A. 2023 Aug;120(31):e2300895120. doi: 10.1073/pnas.2300895120. Epub 2023 Jul 24.
Cutting Edge: Low-dose Recombinant IL-2 Treatment Prevents Autoantibody Responses in Systemic Lupus Erythematosus via Regulatory T Cell-independent Depletion of T Follicular Helper Cells.
Santana S, Papillion A, Foote JB, Bachus H, León B, De Miguel C, Ballesteros-Tato A.
J Immunol. 2024 Oct 15;213(8):1053-1060. doi: 10.4049/jimmunol.2400264.
Allogeneic hematopoietic stem-cell transplantation from haploidentical donors using 'ex-vivo' T-cell depletion in pediatric patients with hematological malignancies: state of the art review.
González-Vicent M, Díaz Perez MA.
Curr Opin Oncol. 2018 Nov;30(6):396-401. doi: 10.1097/CCO.0000000000000480.
T-cell depletion for bone marrow transplantation: effects on graft rejection, graft-versus-host disease, graft-versus-leukemia, and survival.
Champlin RE.
Cancer Treat Res. 1990;50:99-111. doi: 10.1007/978-1-4613-1493-6_6.
CD20+ B cell depletion alters T cell homing.
Kap YS, van Driel N, Laman JD, Tak PP, 't Hart BA.
J Immunol. 2014 May 1;192(9):4242-53. doi: 10.4049/jimmunol.1303125. Epub 2014 Apr 2.
